Adaptyx Biosciences

About Adaptyx Biosciences

Adaptyx is a company focused on transforming healthcare by providing continuous health and biomarker intelligence through AI-powered care. Their mission is to turn lab-grade biochemical assays into a continuous data stream, delivering molecular insights for proactive, always-on healthcare that doesn't stop between visits. They aim to capture the dynamic biochemical story of the body and convert it into a living dataset for truly personalized care.

Products & Services

Adaptyx Platform:A wearable patch with advanced chemistry that replaces traditional lab draws and repeated clinic check-ins by collecting rich, continuous biomarker data from interstitial fluid using minimally-invasive dermal probes and programmable molecular switches. It supports better clinical decisions and helps prevent complications.

Patch Hardware:Advanced electronics that read biochemical signals in real-time, converting molecular information into digital data.

Wearable & Minimally-Invasive Patch:A lightweight and discreet patch that blends into everyday life while delivering clinical-grade insights.

Molecular Switches:Programmable switches that bind specific biomarkers, creating measurable signals for analysis.

Continuous Biomarker Context for AI:Powerful AI analyzes streaming data to detect trends and patterns invisible to single-point tests.

Clinician & AI Agent Insights:Actionable insights empower clinicians and AI agents to make proactive decisions and prevent complications.

Programmable Chemistry Platform:Custom molecular switches for measuring multiple analytes (small molecules, electrolytes, drugs, proteins) simultaneously.

Continuous Molecular Access:A biomarker probe that analyzes interstitial fluid at the required cadence for each condition, without clinic visits.

Intelligent Data & AI Layer:Algorithms that turn multiplexed data streams into continuous trends, clinician dashboards, and AI-assisted insights.

Specialties

Continuous Biomarker Monitoring AI-Powered Healthcare Wearable Technology Molecular Diagnostics Personalized Medicine Therapeutic Drug Monitoring Chronic Disease Management

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Seed T: - FT: Seed	A: 14000000 MR: - FA: 14 million FAN: 14000000	D: 2025-10-20 FD: 2025-10-20	9 investors

Seed Latest

2025-10-20

$14.0M

9 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

V

Vijit Sabnis

Co-Founder & CEO

LinkedIn (Pro only)

A

Alex Yoshikawa

Co-Founder & Chief Science Officer

LinkedIn (Pro only)

P

Pawan Kapur

Co-Founder & Chief Technology Officer

LinkedIn (Pro only)

D

Daniel Grossman

Chief Medical & Business Officer

H

H. Tom Soh

Co-Founder & Scientific Advisor

J

Joseph M. DeSimone

Professor

View 3 more team members with Pro

Unlock Full Team Directory

Recent News